Monoclonal antibodies specific for non-A1C glycated hemoglobin and immunoassay methods

• US 5,183,739 A
• Filed: 02/27/1990
• Issued: 02/02/1993
• Est. Priority Date: 02/27/1990
• Status: Expired due to Term

• Current Assignee: Exocell, Inc. (Glycadia, Inc.)
• Original Assignee: Exocell, Inc. (Glycadia, Inc.)
• Inventors: Cohen, Margo
• Primary Examiner(s): Chan, Y. Christina
• Assistant Examiner(s): Hutzell, Paula
• Application Number:
  US07/485,878
• Time in Patent Office: 1,071 Days
• Field of Search: 530/387, 530/388.7, 435/240.27, 435/70.21, 435/172.2, 435/7.21, 436/547, 436/548
• US Class Current: 435/7.21
• CPC Class Codes: C07K 16/18 against material from animals or humans

Abstract

Monoclonal antibodies specific for an epitope found on hemoglobin glycated both in vivo and in vitro but not found on hemoglobin A_o or hemoglobin A_1c are provided. Use of these antibodies to measure glycohemoglobin levels in the blood provides a measure of the glucose levels in the erythrocyte for the previous 90-120 days. No reduction of the blood sample is required to produce the epitope recognized by the monoclonal antibodies.

Claims

1. A hybridoma which produces an antibody which specifically binds to an epitope on glycohemoglobin comprising epsilon-D-fructosyllysine and not present on hemoglobin A_O, or hemoglobin A_1c or other proteins.

2. The hybridoma of claim 1 which is GLHB which is deposited at the ATCC as accession no. HB10616.

9. A method of producing a monoclonal antibody which specifically binds to an epitope on glycohemoglobin comprising epsilon-D-fructosyllysine and not present on hemoglobin A_o, or hemoglobin A_1c or other proteins, comprising:

growing the hybridoma of claim 1 in a culture medium; and

collecting the culture medium after growth of the hybridoma.

10. The method of claim 9 wherein the hybridoma is GLHB which is deposited at ATCC accession no. HB10616.

3. A monoclonal antibody which specifically binds to an epitope on glycohemoglobin comprising epsilon-D-fructosyllysine and not present on hemoglobin A_o, or hemoglobin A_1c or other proteins.

4. The antibody of claim 3 which binds to synthetic and native glycohemoglobin, wherein synthetic glycohemoglobin is prepared by incubating hemoglobin with glucose in vitro and wherein native glycohemoglobin is obtained from erythrocyte lysates.

5. The antibody of claim 4 which is produced by the hybridoma GLHB deposited at the ATCC as accession no HB10616.

6. A method of measuring the amount of glycohemoglobin in a blood sample, consisting essentially of the steps of:

obtaining a sample of human blood comprising erythrocytes;

lysing the erythrocytes in the sample;

contacting the sample with a monoclonal antibody which specifically binds to an epitope on glycohemoglobin comprising epsilon-D-fructosyllysine and not present on hemoglobin A_o, hemoglobin A_1c or other proteins, said contacting occurring under conditions which allow antibody-antigen reactions to occur;

determining the amount of the monoclonal antibody bound to components of the sample, the amount of antibody bound being proportional to the amount of glycohemoglobin in the sample.

7. The method of claim 6 wherein the monoclonal antibody is GLHB, secreted by the hybridoma having ATCC accession no. HB10616.

8. The method of claim 6 wherein the steps of contacting and determining are performed in an ELISA format.